[Ipilimub for advanced melanoma]

Gan To Kagaku Ryoho. 2015 Apr;42(4):439-42.
[Article in Japanese]
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Ipilimumab
  • Melanoma / drug therapy*
  • Melanoma / mortality
  • Melanoma / pathology
  • Neoplasm Staging
  • Practice Guidelines as Topic

Substances

  • Antibodies, Monoclonal
  • Ipilimumab